Dhami Lakshyajit D, Agarwal Meenakshi
Nanavati Hospital and Vasudhan Arjin Cosmetic Surgery and Laser Center, C-212, Lancelot, S.V. Road, Borivali West, Mumbai 400 092, India.
Aesthetic Plast Surg. 2006 Sep-Oct;30(5):574-88. doi: 10.1007/s00266-006-0050-7.
The advent of the tumescent technique in 1987 allowed for safe total corporal contouring as an ambulatory, single-session megaliposuction with the patient under regional anesthesia supplemented by local anesthetic only in selected areas. Safety and aesthetic issues define large-volume liposuction as having a 5,000-ml aspirate, mega-volume liposuction as having an 8,000-ml aspirate, and giganto-volume liposuction as having an aspirate of 12,000 ml or more. Clinically, a total volume comprising 5,000 ml of fat and wetting solution aspirated during the procedure qualifies for megaliposuction/large-volume liposuction. Between September 2000 and August 2005, 470 cases of liposuction were managed. In 296 (63%) of the 470 cases, the total volume of aspirate exceeded 5 l (range, 5,000-22,000 ml). Concurrent limited or total-block lipectomy was performed in 70 of 296 cases (23.6%). Regional anesthesia with conscious sedation was preferred, except where liposuction targeted areas above the subcostal region (the upper trunk, lateral chest, gynecomastia, breast, arms, and face), or when the patient so desired. Tumescent infiltration was achieved with hypotonic lactated Ringer's solution, adrenalin, triamcinalone, and hyalase in all cases during the last one year of the series. This approach has clinically shown less tissue edema in the postoperative period than with conventional physiologic saline used in place of the Ringer's lactate solution. The amount injected varied from 1,000 to 8,000 ml depending on the size, site, and area. Local anesthetic was included only for the terminal portion of the tumescent mixture, wherever the subcostal regions were infiltrated. The aspirate was restricted to the unstained white/yellow fat, and the amount of fat aspirated did not have any bearing on the amount of solution infiltrated. There were no major complications, and no blood transfusions were administered. The hospital stay ranged from 8 to 24 h for both liposuction and liposuction with a lipectomy. Serous discharge from access sites and serosanguinous fluid accumulation requiring drainage were necessitated in 32 of 296 cases (10.8%). Minor recontouring touch-ups were requested in 17 of 296 cases (5.7%). Early ambulation was encouraged for mobilization of third-space fluid shifts to expedite recovery and to prevent deep vein thrombosis. Follow-up evaluation ranged from 6 to 52 months, with 38 (12.8%) of 296 patients requesting further sessions for other new areas. Average weight reduction observed was 7 to 11.6 kg (approx. 4 to 10% of pre-operative body weight). Meticulous perioperative monitoring of systemic functions ensures safety in tumescent megaliposuction for the obese, and rewarding results are achieved in a single sitting.
1987年肿胀技术的出现,使得安全的全身轮廓塑形成为可能,这是一种在区域麻醉下进行的门诊单阶段超大容量吸脂手术,仅在特定区域辅以局部麻醉。安全性和美学问题将大容量吸脂定义为吸出物为5000毫升,超大容量吸脂为吸出物8000毫升,巨量吸脂为吸出物12000毫升或更多。临床上,手术过程中吸出的脂肪和湿化液总量达5000毫升符合超大容量/大容量吸脂标准。2000年9月至2005年8月,共处理了470例吸脂病例。在这470例病例中的296例(63%),吸出物总量超过5升(范围为5000 - 22000毫升)。296例病例中的70例(23.6%)同时进行了有限或全腹壁切除术。除吸脂目标区域在肋下区域以上(上躯干、侧胸部、男性乳房发育、乳房、手臂和面部)或患者有此要求外,首选区域麻醉加清醒镇静。在该系列的最后一年,所有病例均使用低渗乳酸林格氏液、肾上腺素、曲安奈德和透明质酸酶进行肿胀浸润。与使用传统生理盐水代替乳酸林格氏液相比,这种方法在临床上显示术后组织水肿更少。注入量根据大小、部位和面积从1000到8000毫升不等。仅在肿胀混合物的终末部分(无论何处浸润肋下区域)加入局部麻醉剂。吸出物仅限于未染色的白色/黄色脂肪,吸出的脂肪量与浸润的溶液量无关。未发生重大并发症,也未输血。吸脂手术和吸脂加腹壁切除术的住院时间为8至24小时。296例病例中的32例(10.8%)出现切口浆液性渗出和需要引流的血清样液体积聚。296例病例中的17例(5.7%)要求进行小范围的重新塑形修饰。鼓励早期活动以促进第三间隙液体转移,加快恢复并预防深静脉血栓形成。随访评估时间为6至52个月,296例患者中的38例(12.8%)要求对其他新区域进行进一步手术。观察到的平均体重减轻为7至11.6千克(约占术前体重的4%至10%)。对全身功能进行细致的围手术期监测可确保肥胖患者肿胀超大容量吸脂的安全性,并在单次手术中取得满意效果。